instead, the agency is acting under Section 402 demonstration authority, which permits time-limited testing of "changes in methods of payment or reimbursement. 2 The program was also designed to collect GLP-1 utilization data to share with Part D plan sponsors ahead of potential implementation of the longer-term BALANCE Model
Anytime you have a new service, new procedure, new drug, you definitely want to pay attention to ensure you are capturing accurate data, says Leonta Williams, MBA, RHIA, CPC, CPCO, CRC, CEMC, CHONC, CCS, CCDS, director of education for the American Academy of Professional Coders
The Bottom Line Croaie SMGT-GLP-1 Nano Microneedle Patch is not a clinically tested, doctor-endorsed, or FDA-approved treatment for weight loss or blood sugar regulation
Both promise cleaner cellular function
Moreover, these platforms frequently provide digital tools for tracking progress
& Bauer, J